Viridian Therapeutics to Participate in the Wedbush PacGrow Healthcare Virtual Conference
05 August 2021 - 10:30PM
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical
company advancing new treatments for patients suffering from
serious diseases but underserved by today’s therapies, today
announced that Jonathan Violin, Ph.D., President and Chief
Executive Officer, and Barrett Katz, M.D., M.B.A., Chief Medical
Officer of Viridian, will participate in a panel presentation at
the Wedbush PacGrow Healthcare Virtual Conference, which is
scheduled to take place from August 10 – 11, 2021.
Event: |
The
Wedbush PacGrow Healthcare Virtual Conference |
Panel: |
TED Talk – State of Play in Thyroid Eye Disease (TED) |
Date: |
Wednesday, August 11th |
Fireside Chat Time: |
1:45 p.m. ET |
Webcast information for this event will be accessible on the
Events page under the Investors section of the Viridian
Therapeutics website at www.viridiantherapeutics.com. A replay
of this panel will be archived on the website and available for
approximately 90 days following the live event.
About Viridian Therapeutics
Viridian Therapeutics is a biotechnology company advancing new
treatments for patients suffering from serious diseases but
underserved by today’s therapies. Viridian’s most advanced program,
VRDN-001, is an anti-IGF-1R monoclonal antibody in development for
TED, a debilitating auto-immune disease that causes inflammation
and fibrosis within the orbit of the eye which can cause double
vision, pain, and potential blindness. Patients with severe disease
often require multiple remedial surgeries to the orbit, eye
muscles, and eyelids. Viridian is based in Boulder, Colorado, and
Waltham, Massachusetts. Learn more about Viridian and its programs
at https://www.viridiantherapeutics.com/.
Follow us on Twitter @ViridianThera and on LinkedIn.
Viridian
Contacts:Investors:Dan FerryLifeSci
Advisors617-430-7576IR@viridiantherapeutics.com
Media:Darby PearsonVerge Scientific
Communications703-587-0831PR@viridiantherapeutics.com
Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
From Apr 2024 to May 2024
Viridian Therapeutics (NASDAQ:VRDN)
Historical Stock Chart
From May 2023 to May 2024